back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-06-09 18:37 Tx date 2026-06-05 |
$XENE
Xenon Pharmaceuticals Inc. |
Cannon, Gillian
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-63,236.60
-1,190 vol $53.14 each |
1,455 | |
| Filed 2026-06-05 15:12 Tx date 2026-06-03 |
$XENE
Xenon Pharmaceuticals Inc. |
Cannon, Gillian
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,593 vol |
1,593 | |
| Filed 2026-06-05 15:10 Tx date 2026-06-03 |
$XENE
Xenon Pharmaceuticals Inc. |
Cannon, Gillian
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,507 vol |
71,061 | |
| Filed 2026-06-05 15:08 Tx date 2026-06-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Cannon, Gillian
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,645 vol |
2,645 | |
| Filed 2026-06-05 15:07 Tx date 2023-08-08 |
$XENE
Xenon Pharmaceuticals Inc. |
Cannon, Gillian
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-06-05 15:06 Tx date 2026-06-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Cannon, Gillian
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-2,645 vol |
0 | |
| Filed 2025-06-10 12:29 Tx date 2025-06-05 |
$XENE
Xenon Pharmaceuticals Inc. |
Cannon, Gillian
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
50 - Grant of options
|
+2,645 vol |
2,645 | |
| Filed 2025-06-10 12:26 Tx date 2023-08-08 |
$XENE
Xenon Pharmaceuticals Inc. |
Cannon, Gillian
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-06-10 12:24 Tx date 2025-06-05 |
$XENE
Xenon Pharmaceuticals Inc. |
Cannon, Gillian
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+17,012 vol |
60,554 | |
| Filed 2024-06-13 17:37 Tx date 2024-06-05 |
$XENE
Xenon Pharmaceuticals Inc. |
Cannon, Gillian
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$593,082
+15,542 vol $38.16 each |
43,542 | |
| Filed 2023-08-10 19:30 Tx date 2023-08-10 |
$XENE
Xenon Pharmaceuticals Inc. |
Cannon, Gillian
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+28,000 vol |
28,000 | |
| Filed 2023-08-10 19:28 Tx date 2023-08-08 |
$XENE
Xenon Pharmaceuticals Inc. |
Cannon, Gillian
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|